Greenberg PE - Search Results

1

The economic burden of depression in the United States: how did it change between 1990 and 2000?

Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK. Greenberg PE, et al. J Clin Psychiatry. 2003 Dec;64(12):1465-75. doi: 10.4088/jcp.v64n1211. J Clin Psychiatry. 2003. PMID: 14728109

2

The economic burden of depression in 1990.

Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. Greenberg PE, et al. J Clin Psychiatry. 1993 Nov;54(11):405-18. J Clin Psychiatry. 1993. PMID: 8270583

3

Depression: a neglected major illness.

Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. Greenberg PE, et al. J Clin Psychiatry. 1993 Nov;54(11):419-24. J Clin Psychiatry. 1993. PMID: 8270584

4

The economic burden of anxiety disorders in the 1990s.

Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, Ballenger JC, Fyer AJ. Greenberg PE, et al. J Clin Psychiatry. 1999 Jul;60(7):427-35. doi: 10.4088/jcp.v60n0702. J Clin Psychiatry. 1999. PMID: 10453795

5

Depression in the workplace: effects on short-term disability.

Kessler RC, Barber C, Birnbaum HG, Frank RG, Greenberg PE, Rose RM, Simon GE, Wang P. Kessler RC, et al. Among authors: greenberg pe. Health Aff (Millwood). 1999 Sep-Oct;18(5):163-71. doi: 10.1377/hlthaff.18.5.163. Health Aff (Millwood). 1999. PMID: 10495604

6

Using healthcare claims data for outcomes research and pharmacoeconomic analyses.

Birnbaum HG, Cremieux PY, Greenberg PE, LeLorier J, Ostrander JA, Venditti L. Birnbaum HG, et al. Among authors: greenberg pe. Pharmacoeconomics. 1999 Jul;16(1):1-8. doi: 10.2165/00019053-199916010-00001. Pharmacoeconomics. 1999. PMID: 10539118

7

Pharmacoeconomics and health policy. Current applications and prospects for the future.

Greenberg PE, Arcelus A, Birnbaum HG, Cremieux PY, LeLorier J, Ouellette P, Slavin MB. Greenberg PE, et al. Pharmacoeconomics. 1999 Nov;16(5 Pt 1):425-32. doi: 10.2165/00019053-199916050-00001. Pharmacoeconomics. 1999. PMID: 10662390

8

Savings in direct medical costs from the use of tobramycin solution for inhalation in patients with cystic fibrosis.

LeLorier J, Perreault S, Birnbaum H, Greenberg P, Sheehy O. LeLorier J, et al. Clin Ther. 2000 Jan;22(1):140-51. doi: 10.1016/s0149-2918(00)87985-0. Clin Ther. 2000. PMID: 10688397 Clinical Trial.

9

Direct and indirect costs of rheumatoid arthritis to an employer.

Birnbaum HG, Barton M, Greenberg PE, Sisitsky T, Auerbach R, Wanke LA, Buatti MC. Birnbaum HG, et al. Among authors: greenberg pe. J Occup Environ Med. 2000 Jun;42(6):588-96. doi: 10.1097/00043764-200006000-00006. J Occup Environ Med. 2000. PMID: 10874651

10

The impact of antidepressant use on social functioning: reboxetine versus fluoxetine.

Venditti LN, Arcelus A, Birnbaum H, Greenberg P, Barr CE, Rowland C, Williamson T. Venditti LN, et al. Int Clin Psychopharmacol. 2000 Sep;15(5):279-89. doi: 10.1097/00004850-200015050-00005. Int Clin Psychopharmacol. 2000. PMID: 10993130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters